Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ozgecan Dulgar"'
Publikováno v:
American Journal of Clinical Dermatology. 22:1-10
About half of all cutaneous melanomas harbor activating mutations in the BRAF oncogene. Dependence on this pathway makes the tumors vulnerable to BRAF (and downstream MEK) inhibition, and three drug combinations are approved to target this vulnerabil